PublizoomAward notice Supplies
Farmaceutische producten op basis van amoxicilline/clavulaanzuur 2g/200mg, 1g/200mg en 500mg/50mg (intraveneus)
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Public buyer
- Healthcare Public Procurement (HeCaPP)
Saint-Gilles\Sint-Gillis - Place of performance
- 1000 Bruxelles\Brussel, Brussels-Capital
- Amount awarded
- €546,951 excl. VAT
- Planned end of contract
- 27 March 2029
likely re-tender around September 2028 - Bids received
- 1
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 1 April 2025
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
SPÉCIALITÉS PHARMACEUTIQUES À BASE D'AMOXICILLINE/ACIDE CLAVULANIQUE 2G/200MG, 1G/200MG ET 500MG/50MG (VOIE INTRAVEINEUSE)
Awarded to
- sandoz BCE/KBO 0457.517.227
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 207802-2025.